GSK2292767
CAS: 1254036-66-2
Ref. 3D-EAC03666
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
GSK2292767 is a small molecule that inhibits the protein kinase PI3Kδ. This inhibition blocks the activation of downstream proteins, including epidermal growth factor receptor (EGFR), which are involved in cell maturation and cancer. GSK2292767 has been shown to inhibit the growth of cancer cells in vitro and to reverse certain symptoms in animal models for autoimmune diseases. The drug has also been found to be effective against colorectal cancer and melanoma when used at an effective dose. GSK2292767 targets EGFR, which is important for cell maturation, proliferation, and apoptosis. It also inhibits the activity of PI3Kδ, which leads to the production of inflammatory cytokines by immune cells.
GSK2292767 is currently undergoing clinical trials as a treatment for certain types of cancer.
Propiedades químicas
Consulta técnica sobre: 3D-EAC03666 GSK2292767
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
